RSV Prevention in Newborns: Maternal Vaccination or Antibodies

The Swiss Immunization Schedule 2026 offers two equivalent options for protecting infants against the respiratory syncytial virus during their first season: passive immunization of the child with a long-acting monoclonal antibody, or vaccination of the mother during pregnancy [1]. For gynecologists, this is not just a footnote from pediatrics. The second approach begins in the doctor’s office; it has a narrow time window, and those who choose it are thereby also deciding that the newborn will generally no longer need the antibody.